These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18689300)

  • 21. Incidence of ABO haemolytic disease of the newborn in a group of Hong Kong babies with severe neonatal jaundice.
    Feng CS; Wan CP; Lau J; Lam TK; Fok TF
    J Paediatr Child Health; 1990 Jun; 26(3):155-7. PubMed ID: 2206617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood group distribution and ABO haemolytic disease of the newborn in Jamaica.
    Lindo-Haynes G
    Med Lab Sci; 1980 Jun; 37(3):263-6. PubMed ID: 6783806
    [No Abstract]   [Full Text] [Related]  

  • 23. A correlation between severe haemolytic disease of the fetus and newborn and maternal ABO blood group.
    Doyle B; Quigley J; Lambert M; Crumlish J; Walsh C; McParland P; Culliton M; Murphy K; Fitzgerald J
    Transfus Med; 2014 Aug; 24(4):239-43. PubMed ID: 24975587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interpretation of the direct antiglobulin test in neonates with haemolytic disease of the newborn.
    Tuladhar R; Patole SK; Whitehall JS
    Int J Clin Pract; 2000; 54(1):64. PubMed ID: 10750264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
    Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
    Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Two neonates with severe rhesus antagonism inspite of low values in recent tests of antibody dependent cellular cytotoxicity (ADCC)].
    Janssens LP; Koolen AM; Oei SG; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1823-6. PubMed ID: 10526587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late onset neonatal anaemia due to maternal anti-Kp(b) induced haemolytic disease of the newborn.
    Elhence P; Sachan D; Verma A; Kumar A; Chaudhary R
    Transfus Apher Sci; 2012 Dec; 47(3):247-50. PubMed ID: 23089052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.
    Bennardello F; Curciarello G
    Blood Transfus; 2013 Oct; 11(4):518-27. PubMed ID: 23867179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemolytic disease of the newborn due to antibodies other than ABO and Rh.
    Hildebrandt E
    Can J Med Technol; 1967 Aug; 29(4):132-4. PubMed ID: 6065338
    [No Abstract]   [Full Text] [Related]  

  • 30. [ABO incompatibility and newborn haemolytic disease: two cases with major erythroblastosis].
    Palleau S; Le Tourneau C; Jrad I; Andreux JP; Gouin I; Siguret V
    Ann Biol Clin (Paris); 2004; 62(3):344-8. PubMed ID: 15217770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of soluble recombinant proteins with Kell, Duffy and Lutheran blood group antigen activity, and their use in screening human sera for Kell, Duffy and Lutheran antibodies.
    Ridgwell K; Dixey J; Scott ML
    Transfus Med; 2007 Oct; 17(5):384-94. PubMed ID: 17725551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemolytic disease of the newborn because of rare anti-Vel.
    van Gammeren AJ; Overbeeke MA; Idema RN; van Beek RH; Ten Kate-Booij MJ; Ermens AA
    Transfus Med; 2008 Jun; 18(3):197-8. PubMed ID: 18598283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should we continue screening rhesus D positive women for the development of atypical antibodies in late pregnancy?
    Adeniji AA; Fuller I; Dale T; Lindow SW
    J Matern Fetal Neonatal Med; 2007 Jan; 20(1):59-61. PubMed ID: 17437201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hemolytic disease of the newborn from anti-e.
    McAdams RM; Dotzler SA; Winter LW; Kerecman JD
    J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recombinant erythropoietin as treatment for hyporegenerative anemia following hemolytic disease of the newborn].
    Donato H; Bacciedoni V; García C; Schvartzman G; Vain N
    Arch Argent Pediatr; 2009 Apr; 107(2):119-25. PubMed ID: 19452083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of Newborn.
    Wu Q; Zhang Y; Liu M; Wang B; Liu S; He C
    Neonatology; 2009; 96(1):1-5. PubMed ID: 19129718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutropenia in infants with hemolytic disease of the newborn.
    Blanco E; Johnston DL
    Pediatr Blood Cancer; 2012 Jun; 58(6):950-2. PubMed ID: 21721107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.